Previous Close | 1.5900 |
Open | 1.5900 |
Bid | 1.7600 |
Ask | 1.8100 |
Strike | 97.00 |
Expire Date | 2024-06-28 |
Day's Range | 1.5100 - 1.9100 |
Contract Range | N/A |
Volume | |
Open Interest | 1.17k |
(Bloomberg) -- MapLight Therapeutics has picked Morgan Stanley and Jefferies Financial Group Inc. to lead an initial public offering, according to people familiar with the matter.Most Read from BloombergWhat to Know About the Deadly Flesh-Eating Bacteria Spreading in Japan‘I Live in Hell’: Anti-Growth Fervor Grips US South After Pandemic BoomNvidia’s 591,078% Rally to Most Valuable Stock Came in WavesNvidia Becomes World’s Most Valuable Company as AI Rally Steams AheadI Didn’t Think Biden Affect
In the closing of the recent trading day, Morgan Stanley (MS) stood at $97.57, denoting a +0.55% change from the preceding trading day.
Morgan Stanley shows rising price performance, earning an upgrade to its IBD Relative Strength Rating